Advisor Group’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

Advisor Group’s Portfolio NVIV Stock Details NVIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$0	Hold	1	–	–	﹤0.01%	5643
2019 Q3	$0	Hold	1	–	–	﹤0.01%	5602
2019 Q2	$1K	Hold	1	–	–	﹤0.01%	5195
2019 Q1	$1K	Hold	1	–	–	﹤0.01%	5176
2018 Q4	$1K	Hold	1	–	–	﹤0.01%	5068
2018 Q3	$2K	Hold	1	–	–	﹤0.01%	4917
2018 Q2	$1K	Hold	1	–	–	﹤0.01%	4891
2018 Q1	$7K	Hold	1	–	–	﹤0.01%	4302
2017 Q4	$10K	Hold	1	–	–	﹤0.01%	4121
2017 Q3	$19K	Hold	1	–	–	﹤0.01%	3600
2017 Q2	$32K	Buy	+1	New	+$54.6K	﹤0.01%	3167
2017 Q1	–	Hold	0	–	–	–	3070
2016 Q4	–	Hold	0	–	–	–	3102
2016 Q3	–	Hold	0	–	–	–	2689
2016 Q2	–	Hold	0	–	–	–	2873

Other funds holding NVIV

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

ICM

IMS Capital Management Portland, Oregon $217M AUM 18.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Advisor Group's NVIV Position: Q4 2019 in Review

Advisor Group held its InVivo Therapeutics Holdings Corp (NVIV) position steady in Q4 2019 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5643.

Advisor Group first reported a position in NVIV in Q2 2017 and has held it in 11 quarters since. The position peaked at $32K in Q2 2017. 12 funds tracked by Wall St. Rank hold NVIV as of Q4 2019.

Advisor Group held 1 share of InVivo Therapeutics Holdings Corp worth $0 as of Q4 2019.
Advisor Group left its InVivo Therapeutics Holdings Corp share count unchanged in Q4 2019.
InVivo Therapeutics Holdings Corp made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #5643 holding.
Advisor Group first reported a position in InVivo Therapeutics Holdings Corp in Q2 2017 and has held it in 11 quarters since.
Advisor Group's InVivo Therapeutics Holdings Corp position peaked at $32K in Q2 2017.
12 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.